Samsung Bioepis received marketing approval for Amelivu Inj. (ranibizumab), a biosimilar referencing Lucentis to treat various eye diseases in Korea.However, the local market release of the treatment will take some time due to a patent-related agreement between Samsung Bioepis and Genentech, the dev
Huons said it signed a contract to export three local anesthetic products to Formative Pharma Inc. (FPI), a Canadian-based pharmaceutical company last Thursday.The three products have obtained U.S. Food and Drug Administration’s Abbreviated New Drug Application (ANDA) approval in April 2018, Decembe
Astellas Pharma recently announced it would transform into an oncology drug developer and started reorganizing units and building pipelines for anticancer drug development.In line with the headquarters’ business direction, Astellas Korea also completed the reorganization of the oncology division to
President Yoon Suk-yeol plans to provide Covid-19 vaccines and other medical products for North Korean residents, Cheong Wa Dae Spokesperson Kang In-sun said on Friday.“It is known that the number of suspected infections is surging in North Korea recently due to the outbreak of the Covid-19 pandemic
VUNO said that it has signed a memorandum of understanding with Visual Medica, the largest picture archiving and communication systems (PASC) company in Latin America, to expand its solution into the regional market.Under the accord, VUNO and Visual Medicaq plan to market four of the Korean company’
The turnover of Korean nurses is more than three times higher than the overall industry rate, according to a survey result released Thursday, the International Nurses Day.The National Union of Health and Medical Industry conducted an opinion poll on 27,270 nurses at 145 workplaces.According to its r
Many people recovering from Covid-19 complain about aftereffects, but there are no standardized diagnostic criteria or treatment guidelines, confusing clinical fields, according to medical workers.The larger the number of Covid-19 patients, the more the people suffering from long Covid, with some ex
Korean developers of digital therapeutics (DTx) should prioritize demonstrating how their products work precisely to improve therapeutic effect, an industry expert said.Kim Chi-weon, a partner at Kakao Ventures, shared the status of insurance benefits for local and foreign DTx at Bio Korea 2022 in S
SK Bioscience said on Thursday it obtained the Ministry of Food and Drug Safety’s permit to export SKYTyphoid Multi Inj., a typhoid vaccine.In 2013, SK Bioscience and the International Vaccine Institute (IVI) started jointly developing SKYTyphoid, a conjugate typhoid vaccine.The Bill & Melinda Gates
A research team at Myongji Hospital has proved that taking a low dose (5 mg) of tadalafil, an erectile dysfunction drug, effectively controls blood sugar.According to Myongji researchers, chronic hyperglycemia caused by insufficient insulin secretion or dysfunction, a characteristic of diabetes, is
Digital healthcare companies should prove that their devices can improve the quality of patient care if they want their products to get national health insurance coverage, experts said.The digital healthcare industry should also pursue a shift in people’s perception that using medical devices with d
GC has signed a $51.7 million contract with Pan American Health Organization (PAHO) to supply influenza vaccines to Latin America.GC said it is the largest export deal since it secured PAHO bidding qualifications in 2011, marking a 30 percent increase from the influenza vaccine export to Latin Ameri
South Korea's new government expressed its willingness to cooperate with the North to help Pyongyang effectively combat the Covid-19 pandemic on Thursday.“We hope that the Covid-19 will not spread further but come under control early,” the Unification Ministry said. “The government can always push f
A state-funded research organ has developed a “nasal mask” that can be sprayed. When sprayed on the nasal cavity, the new product reacts with oxygen to remove the virus from the mucosal epithelial cells.The Korea Institute of Science and Technology (KIST) said Thursday that its technology-funded bus
Covid-19 is entering a new phase, but reflections on the existing quarantine system and discussions about future responses are lacking in Korea amid the change of political power, an expert said Wednesday.“Now is the time for the government to consider responses to the future pandemic,” said Lee Jae
SK Biopharmaceuticals’ sales plummeted in the first quarter, compared to a year earlier, due to the base effect of a one-off income from a licensing deal last year.In a public filing on Thursday, the company said it posted 41.1 billion won ($31.8 million) sales in the first three months of 2022, a 7
As cloud-based medical software products such as AI-based diagnostic assistance solutions are rapidly growing, medical institutions need new criteria for patient data management to reduce confusion, an expert said.Lim Joon-seok, head of the Digital Health Division of Yonsei University Health System,
LG Chem said its U.S. partner Cue Biopharma received the FDA approval to conduct a phase 1 trial of CUE-102, an anti-cancer therapy targeting the Wilms Tumor-1 (WT-1) gene.LG Chem owns the exclusive right to develop and market CUE-102 in 11 Asian countries, including Korea, China, and Japan.With the
Korea Disease Control and Prevention Agency (KDCA) found why the Covid-19 variant Omicron’s transmission power was stronger than those of other variants.On Thursday, the Central Disease Control Headquarters released the results of the KDCA’s structural modeling analysis of the spike protein to predi
Amgen announced its achievement in four ESG (Environmental, Social, and Governance) strategic categories in 2021 in a report.Based in the U.S., the multinational pharmaceutical firm released the 2021 ESG Report on Wednesday.The report explained how much the company moved forward in Amgen’s ESG frame